Gaucher's disease overview: Difference between revisions

Jump to navigation Jump to search
Jyostna Chouturi (talk | contribs)
Jyostna Chouturi (talk | contribs)
 
Line 7: Line 7:


==Overview==
==Overview==
'''Gaucher's disease''' (pronounced {{goshay}}) is the most common of the [[lysosomal storage disease]]s. It is caused by a deficiency of the enzyme [[glucocerebrosidase]], leading to an accumulation of its substrate, the fatty substance [[cerebroside|glucocerebroside]] (also known as [[glucosylceramide]]). Fatty material can collect in the [[spleen]], liver, [[kidney]]s, [[lung]]s, [[brain]] and bone marrow. Symptoms may include enlarged spleen and liver, liver malfunction, [[List of skeletal disorders|skeletal disorders]] and bone lesions that may cause pain, severe [[Neurology|neurologic]] complications, swelling of [[lymph node]]s and (occasionally) adjacent joints, distended abdomen, a brownish tint to the skin, [[anemia]], low blood [[platelet]]s and yellow fatty deposits on the [[sclera]]. Persons affected most seriously may also be more susceptible to infection.
'''Gaucher's disease''' (pronounced goshay) is the most common of the [[lysosomal storage disease]]s. It is caused by a deficiency of the enzyme [[glucocerebrosidase]], leading to an accumulation of its substrate, the fatty substance [[cerebroside|glucocerebroside]] (also known as [[glucosylceramide]]). Fatty material can collect in the [[spleen]], liver, [[kidney]]s, [[lung]]s, [[brain]] and bone marrow. Symptoms may include enlarged spleen and liver, liver malfunction, [[List of skeletal disorders|skeletal disorders]] and bone lesions that may cause pain, severe [[Neurology|neurologic]] complications, swelling of [[lymph node]]s and (occasionally) adjacent joints, distended abdomen, a brownish tint to the skin, [[anemia]], low blood [[platelet]]s and yellow fatty deposits on the [[sclera]]. Persons affected most seriously may also be more susceptible to infection.


==References==
==References==

Latest revision as of 18:10, 12 October 2015

Gaucher's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Gaucher's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gaucher's disease overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gaucher's disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gaucher's disease overview

CDC on Gaucher's disease overview

Gaucher's disease overview in the news

Blogs on Gaucher's disease overview

Directions to Hospitals Treating Gaucher's disease

Risk calculators and risk factors for Gaucher's disease overview

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Gaucher's disease (pronounced goshay) is the most common of the lysosomal storage diseases. It is caused by a deficiency of the enzyme glucocerebrosidase, leading to an accumulation of its substrate, the fatty substance glucocerebroside (also known as glucosylceramide). Fatty material can collect in the spleen, liver, kidneys, lungs, brain and bone marrow. Symptoms may include enlarged spleen and liver, liver malfunction, skeletal disorders and bone lesions that may cause pain, severe neurologic complications, swelling of lymph nodes and (occasionally) adjacent joints, distended abdomen, a brownish tint to the skin, anemia, low blood platelets and yellow fatty deposits on the sclera. Persons affected most seriously may also be more susceptible to infection.

References

Template:WH Template:WS